Pyxis Oncology Inc (NAS:PYXS)
$ 3.3 +0.12 (+3.77%) Market Cap: 209.07 Mil Enterprise Value: 186.31 Mil PE Ratio: 0 PB Ratio: 6.60 GF Score: 27/100

Pyxis Oncology Inc at RBC Capital Markets Global Healthcare Conference Transcript

May 19, 2026 / 06:35 PM GMT
Release Date Price: $1.91 (-5.45%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PYXS.OQ - Pyxis Oncology Inc
Pyxis Oncology Inc at RBC Capital Markets Global Healthcare Conference
May 19, 2026 / 06:35PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thanks for joining us for our next session. We've got Pyxis Oncology, represented by their CEO, Tom Tzu.

Thanks for being here.

So a lot of updates for the company, but maybe by way of introduction for those maybe a little less familiar with the story, Mikvos and ADC, pretty unique mechanism of action.

Just tell us a little bit about sort of the drug, why it's different. And what makes it unique and maybe well-suited for head and neck?

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Yeah, so that's a big question. We can go in
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot